| scholarly article | Q13442814 |
| P50 | author | Pei-Qing Liu | Q89508083 |
| P2093 | author name string | Xiaoying Zhang | |
| Zhen Guo | |||
| Zhenzhen Li | |||
| Jingyan Li | |||
| Zhuoming Li | |||
| Panxia Wang | |||
| Yao Zhong | |||
| P2860 | cites work | Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases | Q24537383 |
| NFAT: ubiquitous regulator of cell differentiation and adaptation | Q24673318 | ||
| Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT | Q28139459 | ||
| Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization | Q28143654 | ||
| Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway | Q28255002 | ||
| A calcineurin-dependent transcriptional pathway for cardiac hypertrophy | Q28269300 | ||
| NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression | Q28273795 | ||
| Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity | Q28568033 | ||
| The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy | Q28579323 | ||
| Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
| Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy | Q30825127 | ||
| A Chemical Biology Approach to Reveal Sirt6-targeted Histone H3 Sites in Nucleosomes. | Q33817548 | ||
| Functional role of Calstabin2 in age-related cardiac alterations. | Q34675791 | ||
| The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun | Q35458082 | ||
| SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300. | Q51365104 | ||
| NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy. | Q51463097 | ||
| SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy. | Q52669826 | ||
| [Huangqi Danshen decoction attenuates isoproterenol-induced myocardial remodeling via STIM1, TRPC1, CaN and NFATc3 pathways in rats]. | Q52817006 | ||
| Stress-Activated Protein Kinases in Spinal Cord Injury: Focus on Roles of p38. | Q54121159 | ||
| Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6. | Q54521190 | ||
| Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats. | Q54573202 | ||
| Controllability in an islet specific regulatory network identifies the transcriptional factor NFATC4, which regulates Type 2 Diabetes associated genes. | Q55426178 | ||
| A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp | Q73731442 | ||
| The role and mechanisms of action of SIRT6 in the suppression of postoperative epidural scar formation | Q87479838 | ||
| JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression | Q88647807 | ||
| Hypertrophy of the heart: a new therapeutic target? | Q35739349 | ||
| Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes. | Q36422429 | ||
| Calpain-Calcineurin-Nuclear Factor Signaling and the Development of Atrial Fibrillation in Patients with Valvular Heart Disease and Diabetes | Q36795482 | ||
| SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b | Q36968417 | ||
| Molecular targets and regulators of cardiac hypertrophy. | Q37647071 | ||
| The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications | Q38546358 | ||
| MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes | Q38785040 | ||
| Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases. | Q39003859 | ||
| SIRT6: Novel Mechanisms and Links to Aging and Disease | Q39005741 | ||
| Calcineurin signaling in the heart: The importance of time and place. | Q39050949 | ||
| STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy | Q40695454 | ||
| Inhibition of phosphodiesterase-5 suppresses calcineurin/NFAT- mediated TRPC6 expression in pulmonary artery smooth muscle cells | Q41075480 | ||
| Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway | Q41135875 | ||
| Local microRNA-133a downregulation is associated with hypertrophy in the dyssynchronous heart | Q41239272 | ||
| Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling | Q41520454 | ||
| Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1. | Q46713241 | ||
| Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6. | Q47301606 | ||
| Nuclear sirtuins and inflammatory signaling pathways | Q47353459 | ||
| Perturbations of NAD salvage systems impact mitochondrial function and energy homeostasis in mouse myoblasts and intact skeletal muscle | Q47689677 | ||
| The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis. | Q47858886 | ||
| Expression of nuclear factor of activated T cells (NFAT) and downstream muscle-specific proteins in ground squirrel skeletal and heart muscle during hibernation | Q48099947 | ||
| SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice | Q50098440 | ||
| SIRT6 deacetylase transcriptionally regulates glucose metabolism in heart. | Q50107292 | ||
| Cardiac Development and Transcription Factors: Insulin Signalling, Insulin Resistance, and Intrauterine Nutritional Programming of Cardiovascular Disease | Q50290643 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1519 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy | |
| P478 | volume | 9 |
Search more.